Abstract: The invention concerns an anti-microbial porous part based on a polymeric material grafted at the surface and in its volume with ammonium motifs with anti-microbial and/or bactericidal and/or fungicide activity, preferably benzalkonium. The invention is characterized in that it has a porosity sufficiently high to enable a liquid with compatible viscosity to pass through its structure and sufficiently low to trap contaminating germs within said structure.
Type:
Application
Filed:
September 19, 2005
Publication date:
January 26, 2006
Applicant:
Laboratoire Chauvin S.A.
Inventors:
Mohammed Naji, Bernard Pages, Jacques Lacombe
Abstract: The invention concerns an anti-microbial porous part based on a polymeric material grafted at the surface and in its volume with ammonium motifs with anti-microbial and/or bactericidal and/or fungicide activity, preferably benzalkonium. The invention is characterized in that it has a porosity sufficiently high to enable a liquid with compatible viscosity to pass through its structure and sufficiently low to trap contaminating germs within said structure.
Type:
Grant
Filed:
April 26, 2001
Date of Patent:
January 17, 2006
Assignee:
Laboratoire Chauvin S.A.
Inventors:
Mohammad Naji, Bernard Pages, Jacques Lacombes
Abstract: The invention concerns an ophthalmic composition comprising a beta-blocker solution, said composition being obtained by dissolving in water beta-blocker in the presence of alginic acid and adding an alkaline base, to obtain a solution with the PH of 6 to 8. Said composition has a sustained duration of action.
Type:
Grant
Filed:
December 28, 2000
Date of Patent:
June 4, 2002
Assignee:
Laboratoire Chauvin S.A.
Inventors:
Florence Maurin, Elisabeth Latour, Claude Coquelet
Abstract: The subject of this invention is a ready-for-use collyrium intended for the treatment of ocular allergies, comprising, in aqueous solution, mequitazine and a .beta.- or a .gamma.-cyclodextrin optionally etherified by C.sub.1 -C.sub.4 alkyl or C.sub.1 -C.sub.4 hydroxyalkyl groups, the said cyclodextrin being present in at least a molar ratio of at least one in relation to mequitazine.
Type:
Grant
Filed:
December 5, 1996
Date of Patent:
June 23, 1998
Assignee:
Laboratoire Chauvin S.A.
Inventors:
Claude Coquelet, Elisabeth Latour, Florence Maurin
Abstract: The present invention relates to a ready-to-use indomethacin eye lotion comprising, in aqueous solution:indomethacin,a .beta.- or .gamma.-cyclodextrin etherified with C.sub.1 -C.sub.4 alkyl or C.sub.1 -C.sub.4 hydroxyalkyl groups, the cyclodextrin being present in a molar ratio with respect to the indomethacin of at least 10/1, and the pH of the solution being from 4.0 to 6.0.
Type:
Grant
Filed:
September 4, 1996
Date of Patent:
April 28, 1998
Assignee:
Laboratoire Chauvin S.A.
Inventors:
Florence Maurin, Bernard Pages, Claude Coquelet